Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8319
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease ; day:24 ; month:3 ; year:2021 ; pages:1-7
Aging clinical and experimental research ; (24.3.2021), 1-7
- Urheber
-
Devita, Maria
Masina, Fabio
Mapelli, Daniela
Anselmi, Pasquale
Sergi, Giuseppe
Coin, Alessandra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40520-021-01837-8
- URN
-
urn:nbn:de:101:1-2021050915082459256460
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Devita, Maria
- Masina, Fabio
- Mapelli, Daniela
- Anselmi, Pasquale
- Sergi, Giuseppe
- Coin, Alessandra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review
Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan
Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain
Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review
Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan
Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain
Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
Association of the Choline Acetyltransferase Gene with Responsiveness to Acetylcholinesterase Inhibitors in Alzheimer’s Disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review
Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan
Potencies and Selectivities of Inhibitors of Acetylcholinesterase and Its Molecular Forms in Normal and Alzheimer’s Disease Brain
Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach